Jakobi, K.;                     Beyer, S.;                     Koch, A.;                     Thomas, D.;                     Schwalm, S.;                     Zeuzem, S.;                     Pfeilschifter, J.;                     Grammatikos, G.    
        Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro. Int. J. Mol. Sci. 2020, 21, 2409.
    https://doi.org/10.3390/ijms21072409
    AMA Style
    
                                Jakobi K,                                 Beyer S,                                 Koch A,                                 Thomas D,                                 Schwalm S,                                 Zeuzem S,                                 Pfeilschifter J,                                 Grammatikos G.        
                Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro. International Journal of Molecular Sciences. 2020; 21(7):2409.
        https://doi.org/10.3390/ijms21072409
    
    Chicago/Turabian Style
    
                                Jakobi, Katja,                                 Sandra Beyer,                                 Alexander Koch,                                 Dominique Thomas,                                 Stephanie Schwalm,                                 Stefan Zeuzem,                                 Josef Pfeilschifter,                                 and Georgios Grammatikos.        
                2020. "Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro" International Journal of Molecular Sciences 21, no. 7: 2409.
        https://doi.org/10.3390/ijms21072409
    
    APA Style
    
                                Jakobi, K.,                                 Beyer, S.,                                 Koch, A.,                                 Thomas, D.,                                 Schwalm, S.,                                 Zeuzem, S.,                                 Pfeilschifter, J.,                                 & Grammatikos, G.        
        
        (2020). Sorafenib Treatment and Modulation of the Sphingolipid Pathway Affect Proliferation and Viability of Hepatocellular Carcinoma In Vitro. International Journal of Molecular Sciences, 21(7), 2409.
        https://doi.org/10.3390/ijms21072409